- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Carcinoid syndrome
- Meeting Date: July 2005
Lanreotide Acetate – July 2007
Lanreotide Acetate, pre-filled syringe, 60 mg in 0.3mL (base), 90 mg in 0.3 mL (base) and 120 mg in 0.5 mL (base), Somatuline Autogel®, July 2005
Last updated
27 June 2025
